115 related articles for article (PubMed ID: 8133401)
1. Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochemical study.
Joypaul BV; Newman EL; Hopwood D; Grant A; Qureshi S; Lane DP; Cuschieri A
J Pathol; 1993 Jul; 170(3):279-83. PubMed ID: 8133401
[TBL] [Abstract][Full Text] [Related]
2. Study of p53 immunostaining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis.
Teh M; Tan KB; Seet BL; Yeoh KG
Cancer; 2002 Aug; 95(3):499-505. PubMed ID: 12209741
[TBL] [Abstract][Full Text] [Related]
3. Analysis of p53 expression in precancerous and malignant gastric mucosa.
Romiti A; Moretti A; Vecchione A; Muraro R; Feudi ML; Rinaldi V; Mancini R; Valli C; Mozzicafreddo A; Frati L; Tomao S
Oncol Rep; 1998; 5(1):109-13. PubMed ID: 9458303
[TBL] [Abstract][Full Text] [Related]
4. High incidence of nuclear accumulation of p53 protein in gastric cancer.
Uchino S; Noguchi M; Hirota T; Itabashi M; Saito T; Kobayashi M; Hirohashi S
Jpn J Clin Oncol; 1992 Aug; 22(4):225-31. PubMed ID: 1279244
[TBL] [Abstract][Full Text] [Related]
5. p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps.
Lauwers GY; Wahl SJ; Melamed J; Rojas-Corona RR
Am J Gastroenterol; 1993 Nov; 88(11):1916-9. PubMed ID: 8237942
[TBL] [Abstract][Full Text] [Related]
6. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
7. Prognostic influence of p53 expression in gastric cancer.
Müller W; Borchard F
J Pathol; 1996 Mar; 178(3):255-8. PubMed ID: 8778328
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
9. Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development.
Sasaki I; Yao T; Nawata H; Tsuneyoshi M
Cancer; 1999 Apr; 85(8):1719-29. PubMed ID: 10223565
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of the immunohistochemical detection of p53 protein in endoscopic biopsy specimens.
Jiang H; Han P; Jiang Y; Liang X; Hu C; Yang D
Chin Med J (Engl); 1997 Mar; 110(3):202-5. PubMed ID: 9594341
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evidence of p53 overexpression in gastric epithelial dysplasia.
Rugge M; Shiao YH; Correa P; Baffa R; DiMario F
Cancer Epidemiol Biomarkers Prev; 1992; 1(7):551-4. PubMed ID: 1302567
[TBL] [Abstract][Full Text] [Related]
12. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Karagiannis J; Paraskeva K; Chalkley L; Habilomati E; Tsianos E; Agnantis NJ
J Gastroenterol Hepatol; 2008 Apr; 23(4):626-31. PubMed ID: 18397488
[TBL] [Abstract][Full Text] [Related]
14. Low presence of p53 abnormalities in H pylori-infected gastric mucosa and in gastric adenocarcinoma.
Berloco P; Russo F; Cariola F; Gentile M; Giorgio P; Caruso ML; Valentini AM; Di Matteo G; Di Leo A
J Gastroenterol; 2003; 38(1):28-36. PubMed ID: 12560919
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between expression of tumor suppressor protein p21 and p53 and cell proliferation in the gastric carcinoma].
Huang J; Gan J
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(5):441-3. PubMed ID: 10682555
[TBL] [Abstract][Full Text] [Related]
16. p53 and Ki-67 expression in epithelial gastric dysplasia and in gastric cancer.
Testino G; Gada D; De Iaco F; Cornaggia M
Panminerva Med; 2002 Dec; 44(4):369-71. PubMed ID: 12434121
[TBL] [Abstract][Full Text] [Related]
17. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
[TBL] [Abstract][Full Text] [Related]
19. Different characteristics of carcinoma in the gastric remnant: histochemical and immunohistochemical studies.
Matsui N; Yao T; Akazawa K; Nawata H; Tsuneyoshi M
Oncol Rep; 2001; 8(1):17-26. PubMed ID: 11115563
[TBL] [Abstract][Full Text] [Related]
20. Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas.
Tashima S; Shimada S; Yamaguchi K; Tsuruta J; Ogawa M
Am J Gastroenterol; 2000 Jan; 95(1):255-63. PubMed ID: 10638593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
